A new study says that improved access to antiretroviral medications and support to help HIV-infected mothers continue taking their medication will help in eliminating new infant HIV infections in Zimbabwe. This are the findings presented in an article in the January issue of PLoS Medicine.
Findings of the report from an international research team should help with the planning of expanded programs to prevent mother-to-child HIV transmission in sub-Saharan Africa and other areas with limited health resources.
"Pediatric HIV infection has been nearly eliminated in resource-rich settings, such as the U.S. and Europe, through a combination of anti-HIV drugs and avoidance of breastfeeding," says Andrea Ciaranello, MD, MPH, of the Massachusetts General Hospital (MGH) division of Infectious Diseases, lead author of the PLOS Medicine report. "The World Health Organization has urged health programs throughout the world to aim for the same successes, calling for the 'virtual elimination' - defined as reducing transmission risk to less than 5 percent - of mother-to-child HIV transmission.
Using a previously validated computer simulation model, the researchers compared the country's current prevention program, which provides three-drug antiretroviral therapy to pregnant women with advanced HIV infection and a single dose of the antiviral drug nevirapine for all others, with two new antiviral regimens recommended by the WHO in 2010. While the existing Zimbabwean program, which reached more than half the country's HIV-infected pregnant women in 2009, led to a transmission rate of 18 percent, the authors found that rate could be decreased to 14 percent with even greater participation and the use of newer medications. Mother-to-child transmission could be further reduced to 6 to 7 percent - approaching "virtual elimination" - if three goals can be reached: more than 95 percent of infected pregnant women receive the most effective available medications; excellent medication adherence is maintained for both mothers and infants throughout pregnancy and breastfeeding; and breastfeeding is safely reduced or avoided altogether, an achievement that requires access to both adequate infant formula and safe drinking water.
"Ambitious public health targets are critical to spurring major expansions of global health care services, but it is important to understand what it would take to reach these goals," says senior author Kenneth A. Freedberg, MD, MSc, also of the MGH division of Infectious Diseases. "Achieving 'virtual elimination' will require increased access to WHO-recommended medications, dedicated support for long-term medication adherence and safer infant feeding options." Freedberg is a professor of Medicine and Ciaranello is an instructor in Medicine at Harvard Medical School.